Coronavirus plays – vaccines, drugs & infection control products

Below are companies that have announced plans to develop either vaccines or therapies for COVID-19 or are suppliers of infection control products. Again, some are more credible than others.

Vaccines: Sanofi (SNY -1.5%), iBio (IBIO -10.2%), Vaxart (VXRT -10.7%), Inovio Pharmaceuticals (INO +17.1%), Novavax (NVAX -14.4%), Moderna (MRNA -4.9%), Dynavax Technologies (DVAX -4.3%), Tonix Pharmaceuticals (TNXP -12.1%), Heat Biologics (HTBX -21.7%), GlaxoSmithKline (GSK -2.8%)
Therapeutics: Regeneron Pharmaceuticals (REGN -1.7%), Gilead Sciences (GILD -3.6%), Johnson & Johnson (JNJ -3.5%), BioCryst Pharmaceuticals (BCRX -6%), Cocrystal Pharma (COCP -15%), NanoViricides (NNVC -8.2%), Cleveland BioLabs (CBLI -10.9%), Vir Biotechnology (VIR -12.2%)
Infection control products: Lakeland Industries (LAKE +4.7%), Allied Healthcare Products (AHPI +41.2%), Alpha Pro Tech (APT +24.9%), 3M Company (MMM -4.4%), Ocean Bio-Chem (OBCI -2.3%), China Pharma Holdings (CPHI -30.7%)
https://seekingalpha.com/news/3548189-coronavirus-plays-vaccines-drugs-infection-control-products